| 5126 |
PORTERS Corporation
|
Earnings |
|
Notice of Revision to Full-Year Earnings Forecast and Expected Incurrence of Extraordinary Loss
|
Sep 30, 2026
|
| 5105 |
Toyo Tire Corporation
|
Share Buyback |
|
Notice of Completion of Treasury Stock Cancellation
|
Sep 30, 2026
|
| 4971 |
MEC Company Ltd.
|
Other |
|
Notice Regarding Acquisition of Fixed Assets
|
Sep 30, 2026
|
| 4971 |
MEC Company Ltd.
|
Strategy |
|
Notice Regarding Additional Capital Expenditure for Production Capacity Expansion (Acquisition of Fixed Assets)
|
Sep 30, 2026
|
| 4933 |
I-ne CO., LTD.
|
Earnings |
|
Frequently Asked Questions and Answers Regarding the Second Quarter Financial Results for the Fiscal Year Ending December 2026
|
Sep 30, 2026
|
| 4875 |
MediciNova, Inc.
|
Personnel |
|
Notice of Change in Major Shareholders
|
Sep 30, 2026
|
| 4840 |
TriIs Incorporated
|
M&A |
|
Notice of Basic Agreement on the Joint Venture of LIMNO Co., Ltd. with Icom, Inc.
|
Sep 30, 2026
|
| 4813 |
Access Co., Ltd.
|
Strategy |
|
Notice of Execution of Commitment Line Agreement with Financial Covenants
|
Sep 30, 2026
|
| 4776 |
Cybozu, Inc.
|
Earnings |
|
Notice of Monthly Consolidated Net Sales for August 2026
|
Sep 30, 2026
|
| 4665 |
Duskin Co., Ltd.
|
Personnel |
|
Notice of Personnel Changes
|
Sep 30, 2026
|
| 4593 |
Healios K.K.
|
Other |
|
Notice Regarding Change of Shipment Timing for Initial Order of Conditioned Media Products to JENECELL
|
Sep 30, 2026
|
| 4586 |
MedRx Co., Ltd
|
M&A |
|
Regarding U.S. Sales Partnership with Terrain for “Bondlido” and Launch Timing
|
Sep 30, 2026
|
| 4577 |
Daito Pharmaceutical Co.,Ltd.
|
M&A |
|
Daito Pharmaceutical Co.,Ltd. to Establish Jointly Funded Company for Succession of Kyorin Pharmaceutical’s Generic Drug Business and Conclude Share Transfer Agreement
|
Sep 30, 2026
|
| 4576 |
D. Western Therapeutics Institute, Inc.
|
Other |
|
Regarding U.S. Distribution Partnership and Launch Timing for Bondlido
|
Sep 30, 2026
|
| 4569 |
KYORIN Pharmaceutical Co., Ltd.
|
M&A |
|
Notice Regarding Transfer of Generic Pharmaceuticals Business
|
Sep 30, 2026
|
| 4538 |
Fuso Pharmaceutical Industries,Ltd.
|
Strategy |
|
Notice of Execution of Design and Construction Contract for Okayama No.2 Plant
|
Sep 30, 2026
|
| 4442 |
Valtes Holdings Co.,Ltd.
|
M&A |
|
Notice of Completion of Share Acquisition (Subsidiarization)
|
Sep 30, 2026
|
| 4398 |
BroadBand Security, Inc.
|
Other |
|
Matters Concerning Controlling Shareholders, etc.
|
Sep 30, 2026
|
| 4395 |
Accrete Inc.
|
Personnel |
|
(Interim Disclosure) Notice Regarding Appointment of Temporary Accounting Auditor
|
Sep 30, 2026
|
| 4395 |
Accrete Inc.
|
Personnel |
|
Progress Disclosure) Notice Regarding Exercise of Stock Acquisition Rights
|
Sep 30, 2026
|
